Activist Wins Two Exxon Board Seats
Despite the victory for Engine No. 1, we do not expect a wholesale change in strategy.
Two of activist Engine No. 1’s four Exxon (XOM) board nominees won shareholder backing on May 26. Including those two, eight board members were elected, while the outcome for five nominees, including the activist’s third candidate, was yet to be determined. Engine No. 1’s fourth nominee was not elected. Even if only two of its candidates are elected in the end, it marks a victory for Engine No. 1.
We expect the implications for Exxon and investors will likely be less dramatic than the vote, however, as Exxon has already moved toward several of the activists' demands, including greater capital discipline and the introduction of emissions targets. Also, even if the third nominee is eventually elected, the new members will be in the minority. That said, Exxon likely will have to make some additional concessions given Engine No. 1’s initial success could be the blood in the water that attracts more activist action. As such, Exxon will likely make greater progress toward Engine No. 1’s calls for more long-term planning, including exploring new business areas and setting emission targets, greater focus on returns and likely less spending, and correspondingly aligned management compensation incentives.
We do not expect a wholesale change in strategy, however. As such, our fair value estimate and moat rating are unchanged. The election of the new members was likely more a function of investor dissatisfaction around recent financial and share price performance than a call for an overhaul of the core strategy. Past actions, such as ill-timed acquisitions and investments in high-cost assets like oil sands have resulted in Exxon squandering its historical leadership in returns on capital relative to peers.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
Allen Good does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.